JOINT CORP/THE (JYNT) Fundamental Analysis & Valuation

NASDAQ:JYNT • US47973J1025

Current stock price

8.55 USD
+0.2 (+2.4%)
At close:
8.55 USD
0 (0%)
After Hours:

This JYNT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. JYNT Profitability Analysis

1.1 Basic Checks

  • In the past year JYNT has reported negative net income.
  • In the past year JYNT had a positive cash flow from operations.
  • In multiple years JYNT reported negative net income over the last 5 years.
  • In the past 5 years JYNT always reported a positive cash flow from operatings.
JYNT Yearly Net Income VS EBIT VS OCF VS FCFJYNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M -15M

1.2 Ratios

  • JYNT has a Return On Assets of 4.50%. This is in the better half of the industry: JYNT outperforms 72.00% of its industry peers.
  • JYNT has a Return On Equity of 18.21%. This is amongst the best in the industry. JYNT outperforms 85.00% of its industry peers.
Industry RankSector Rank
ROA 4.5%
ROE 18.21%
ROIC N/A
ROA(3y)-4.46%
ROA(5y)-0.8%
ROE(3y)-16.05%
ROE(5y)-4.24%
ROIC(3y)N/A
ROIC(5y)N/A
JYNT Yearly ROA, ROE, ROICJYNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

1.3 Margins

  • JYNT's Profit Margin of 4.99% is fine compared to the rest of the industry. JYNT outperforms 78.00% of its industry peers.
  • In the last couple of years the Profit Margin of JYNT has declined.
  • JYNT's Gross Margin of 79.55% is amongst the best of the industry. JYNT outperforms 93.00% of its industry peers.
  • JYNT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 4.99%
GM 79.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y107.56%
PM growth 5Y-25.11%
GM growth 3Y-4.35%
GM growth 5Y-2.2%
JYNT Yearly Profit, Operating, Gross MarginsJYNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

7

2. JYNT Health Analysis

2.1 Basic Checks

  • JYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • JYNT has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for JYNT remains at a similar level compared to 5 years ago.
  • JYNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
JYNT Yearly Shares OutstandingJYNT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
JYNT Yearly Total Debt VS Total AssetsJYNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • JYNT has an Altman-Z score of 2.24. This is not the best score and indicates that JYNT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of JYNT (2.24) is comparable to the rest of the industry.
  • There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.24
ROIC/WACCN/A
WACC9.08%
JYNT Yearly LT Debt VS Equity VS FCFJYNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 1.59 indicates that JYNT should not have too much problems paying its short term obligations.
  • The Current ratio of JYNT (1.59) is better than 64.00% of its industry peers.
  • JYNT has a Quick Ratio of 1.59. This is a normal value and indicates that JYNT is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of JYNT (1.59) is better than 66.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.59
JYNT Yearly Current Assets VS Current LiabilitesJYNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

4

3. JYNT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 98.85% over the past year.
  • The earnings per share for JYNT have been decreasing by -26.73% on average. This is quite bad
  • The Revenue for JYNT has decreased by -61.36% in the past year. This is quite bad
  • Measured over the past years, JYNT shows a decrease in Revenue. The Revenue has been decreasing by -1.33% on average per year.
EPS 1Y (TTM)98.85%
EPS 3Y68.1%
EPS 5Y-26.73%
EPS Q2Q%12.43%
Revenue 1Y (TTM)-61.36%
Revenue growth 3Y-18.47%
Revenue growth 5Y-1.33%
Sales Q2Q%4.98%

3.2 Future

  • JYNT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 850.51% yearly.
  • JYNT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.29% yearly.
EPS Next Y15761.42%
EPS Next 2Y850.51%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.37%
Revenue Next 2Y3.29%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
JYNT Yearly Revenue VS EstimatesJYNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
JYNT Yearly EPS VS EstimatesJYNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

2

4. JYNT Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Forward Earnings ratio of 21.49, the valuation of JYNT can be described as rather expensive.
  • JYNT's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 22.10. JYNT is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 21.49
JYNT Price Earnings VS Forward Price EarningsJYNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, JYNT is valued a bit more expensive than 67.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, JYNT is valued a bit more expensive than 65.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 360.44
EV/EBITDA 120.07
JYNT Per share dataJYNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • JYNT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as JYNT's earnings are expected to grow with 850.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y850.51%
EPS Next 3YN/A

0

5. JYNT Dividend Analysis

5.1 Amount

  • JYNT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

JYNT Fundamentals: All Metrics, Ratios and Statistics

JOINT CORP/THE

NASDAQ:JYNT (3/30/2026, 8:12:40 PM)

After market: 8.55 0 (0%)

8.55

+0.2 (+2.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-12
Earnings (Next)05-06
Inst Owners74.6%
Inst Owner Change-4.79%
Ins Owners12.64%
Ins Owner Change4.79%
Market Cap120.64M
Revenue(TTM)54.90M
Net Income(TTM)2.74M
Analysts76
Price Target10.2 (19.3%)
Short Float %8.31%
Short Ratio13.9
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.12%
Min Revenue beat(2)-1.81%
Max Revenue beat(2)6.04%
Revenue beat(4)1
Avg Revenue beat(4)0.09%
Min Revenue beat(4)-2.34%
Max Revenue beat(4)6.04%
Revenue beat(8)3
Avg Revenue beat(8)-5.88%
Revenue beat(12)4
Avg Revenue beat(12)-4.12%
Revenue beat(16)6
Avg Revenue beat(16)-3.36%
PT rev (1m)-6.25%
PT rev (3m)-6.98%
EPS NQ rev (1m)-18.75%
EPS NQ rev (3m)-18.75%
EPS NY rev (1m)0%
EPS NY rev (3m)-18.18%
Revenue NQ rev (1m)2.4%
Revenue NQ rev (3m)2.4%
Revenue NY rev (1m)8.19%
Revenue NY rev (3m)5.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 21.49
P/S 2.2
P/FCF 360.44
P/OCF 65.62
P/B 8.01
P/tB 8.01
EV/EBITDA 120.07
EPS(TTM)0
EYN/A
EPS(NY)0.4
Fwd EY4.65%
FCF(TTM)0.02
FCFY0.28%
OCF(TTM)0.13
OCFY1.52%
SpS3.89
BVpS1.07
TBVpS1.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 4.5%
ROE 18.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 4.99%
GM 79.55%
FCFM 0.61%
ROA(3y)-4.46%
ROA(5y)-0.8%
ROE(3y)-16.05%
ROE(5y)-4.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y107.56%
PM growth 5Y-25.11%
GM growth 3Y-4.35%
GM growth 5Y-2.2%
F-Score6
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 87.75%
Cap/Sales 2.74%
Interest Coverage N/A
Cash Conversion 227.48%
Profit Quality 12.21%
Current Ratio 1.59
Quick Ratio 1.59
Altman-Z 2.24
F-Score6
WACC9.08%
ROIC/WACCN/A
Cap/Depr(3y)57.04%
Cap/Depr(5y)87.63%
Cap/Sales(3y)5.22%
Cap/Sales(5y)6.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.85%
EPS 3Y68.1%
EPS 5Y-26.73%
EPS Q2Q%12.43%
EPS Next Y15761.42%
EPS Next 2Y850.51%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-61.36%
Revenue growth 3Y-18.47%
Revenue growth 5Y-1.33%
Sales Q2Q%4.98%
Revenue Next Year12.37%
Revenue Next 2Y3.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y75.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1256.06%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-95.93%
FCF growth 3Y-47.48%
FCF growth 5Y-47.02%
OCF growth 1Y-80.47%
OCF growth 3Y-39.27%
OCF growth 5Y-30.3%

JOINT CORP/THE / JYNT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of JOINT CORP/THE (JYNT) stock?

ChartMill assigns a fundamental rating of 4 / 10 to JYNT.


Can you provide the valuation status for JOINT CORP/THE?

ChartMill assigns a valuation rating of 2 / 10 to JOINT CORP/THE (JYNT). This can be considered as Overvalued.


How profitable is JOINT CORP/THE (JYNT) stock?

JOINT CORP/THE (JYNT) has a profitability rating of 4 / 10.


How financially healthy is JOINT CORP/THE?

The financial health rating of JOINT CORP/THE (JYNT) is 7 / 10.